vimarsana.com
Home
Live Updates
Brainomix Announces the Development of a Proprietary AI-Trai
Brainomix Announces the Development of a Proprietary AI-Trai
Brainomix Announces the Development of a Proprietary AI-Trained Predictive Biomarker for Idiopathic Pulmonary Fibrosis (IPF)
The imaging biomarker has demonstrated superior prognostic value compared with traditional measures, and may provide a more reliable measurement of the effects of novel therapies in clinical
Related Keywords
Elizabeth Estes ,
Kostenloser Wertpapierhandel ,
Prnewswire Brainomix ,
Linkedin ,
University Of Oxford ,
Twitter ,
Facebook ,
Source Imaging Consortium ,
Open Source Imaging Consortium ,
Forced Vital Capacity ,
Executive Director ,
Pulmonary Fibrosis ,
Brainomix ,
Nnounces ,
Development ,
Roprietary ,
Trained ,
Predictive ,
Biomarker ,
Idiopathic ,
Pulmonary ,
Ibrosis ,